2021
DOI: 10.5114/ceh.2021.107122
|View full text |Cite
|
Sign up to set email alerts
|

Treg cells in the course of chronic hepatitis C virus infection partially normalize in longitudinal observation after successful DAA treatment regardless of hepatic fibrosis stage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 38 publications
(45 reference statements)
0
3
0
Order By: Relevance
“…Although the percentages of Treg in normal ALT levels were higher than those of the patients with high ALT levels, no statistically significant difference was observed in percentages of Treg between CHC patients with high ALT levels and normal ALT levels (23). Likewise, there was no correlation between APRI and FIB-4 scores and Treg percentages, probably because the AST and platelet values used in this scoring did not deviate much from the normal values due to the relatively mild clinics of the CHC patients included in the study (24).…”
Section: Discussionmentioning
confidence: 78%
“…Although the percentages of Treg in normal ALT levels were higher than those of the patients with high ALT levels, no statistically significant difference was observed in percentages of Treg between CHC patients with high ALT levels and normal ALT levels (23). Likewise, there was no correlation between APRI and FIB-4 scores and Treg percentages, probably because the AST and platelet values used in this scoring did not deviate much from the normal values due to the relatively mild clinics of the CHC patients included in the study (24).…”
Section: Discussionmentioning
confidence: 78%
“…However, the effect of CD4 on liver fibrosis appears to be insignificant. For example, while the number of CD4 + T cells is reduced after antiviral therapy, HCV hepatic fibrosis is not alleviated (40). Moreover, there is no significant difference in CD4 + lymphocytes between patients with non-alcoholic hepatic fibrosis and controls (40,41).…”
Section: Results Of the Ppi Network Analysismentioning
confidence: 97%
“…For example, while the number of CD4 + T cells is reduced after antiviral therapy, HCV hepatic fibrosis is not alleviated (40). Moreover, there is no significant difference in CD4 + lymphocytes between patients with non-alcoholic hepatic fibrosis and controls (40,41). The analysis results of a study on CD4 + T lymphocytes and hepatic fibrosis did not comply with the expected assumptions, and no other relevant studies have been conducted; however, this issue is worthy of further in-depth study.…”
Section: Results Of the Ppi Network Analysismentioning
confidence: 99%